top of page

Our Revolutionary Products

Discover our flagship products that combine cutting-edge technology with sustainable practices to deliver premium solutions for clean-tech and wellness markets.

WhatsApp Image 2025-08-12 at 14.26.46_29da4bcc.jpg
Siyaras NK Cell Booster™

Enhance your immunity with Siyaras NK Cell Booster (TM). Available in Indian capsule variant and

African effervescent sachet variant. Scientifically formulated with herbal and modern ingredients to

boost Natural Killer (NK) cell activity and overall immune response.

Key Benefits:

-Boosts natural killer cell activity, strengthens immune response, supports overall wellness, and provides antioxidant protection

 â‚¹999/Bottle
WhatsApp Image 2025-08-12 at 14.26.46_0398a1f9.jpg
EcoPod™ 

EcoPod (TM) is a patented refillable smart capsule system designed for zero-waste daily

consumables. It incorporates IoT-based usage tracking, enabling users to monitor and control

consumption in real-time. The product supports tablets, powders, and liquids, and is compatible with

various supplements and daily consumables

Key Benefits:

-Refillable design reducing waste

- Smart IoT usage tracking

- Compatible with powders and liquids

₹2499/unit

Why Our Products Stand Out

Each product is meticulously designed with cutting-edge technology and sustainable practices.

Siyaras International

Premium innovation-driven enterprise specializing in clean-tech, sustainable energy solutions, and wellness supplements tailored for emerging global markets.

India Office

Registered office

Siyaras International , Congress  para , Balurghat , 733101 , West Bengal , India

Corporate Office

Suit 1401, Tower 14, Sunteck maxxworld , Mumbai 401208

Nigeria Office

Coming soon

​

Global Offices

India (Headquarters)
Suit 1401, Tower 14, Sunteck maxxworld, Mumbai 401208

Quick Contact

© 2025  Siyaras International Pvt. Ltd. All rights reserved.

Products

Website

Phone

Company

Email

  • Instagram

Registered in India•CIN: U21003WB2024PTC270864

Nigeria (Coming soon)
Opening Q2 2025

bottom of page